Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area
NCT04534868 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2020-09-01
Summary
The aim objective of this work is to assess the characteristics of patients for whom teledermoscopy could be suitable for the detection of potential skin cancers, within a population of rural general medicine in the South of Hainaut, by means of a mixed quantitative and qualitative study corresponding respectively:
* To identify patients' knowledge of skin cancers, their skin monitoring habits, and their acceptability of new telemedicine tools such as teledermoscopy ("Part 1").
* To evaluate the satisfaction and expectations of those who benefit from teledermoscopy ("Part 2").
Conditions
- Skin Cancer
- Patient Acceptance of Health Care
- Patient Satisfaction
Interventions
- OTHER
-
taking macroscopic and dermoscopic pictures of suspicious skin lesions
If there is any diagnostic doubt about a skin lesion, teledermoscopy will be used, if the patient agrees. * A table containing the useful information about the patient for the lesion's analysis will be completed. * The pictures will be taken with a Fotofinder Handyscope. The photos will be integrated into the patient's electronic medical record (CareConnect program). * The photo is anonymized via a serial number assigned by the "Handyscope" application. * Sending photos and information via a secure email address to the dermatologists. * Response from the dermatologist (Prof. Tromme or Dr Harkemanne) in the following days also via email. * Contact (consultation or telephone call depending on the diagnosis) with the patient to communicate the results and the procedure to be followed. * This information (emails containing the dermatological report) will be saved in the patient's computerized medical file (CareConnect program) then deleted from the mailbox
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-15
- Primary Completion
- 2021-02-15
- Completion
- 2021-03-15
More Related Trials
-
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
NCT03477448 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
NCT00228332 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery
NCT01212562 ·Status: COMPLETED
-
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
NCT00175643 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
NCT00066872 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
NCT02724254 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients
NCT03153566 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base
NCT00463359 ·Status: UNKNOWN ·Phase: NA
-
Biofields Therapy on Warts
NCT02773719 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study
NCT05902624 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
NCT00696488 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment
NCT02861404 ·Status: TERMINATED
-
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453
NCT02052687 ·Status: COMPLETED ·Phase: PHASE1
-
Cantharidin and Occlusion in Verruca Epithelium
NCT03487549 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
NCT03051880 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
NCT00314756 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
NCT00865644 ·Status: COMPLETED ·Phase: PHASE1
-
Vulvar Paget Disease
NCT03900975 ·Status: COMPLETED
-
Intralesional Treatment of Plantar Wart
NCT05057663 ·Status: UNKNOWN ·Phase: NA
-
HPV Vaccine Hesitancy Among Indiana Youth With Cancer and Blood Diseases
NCT04667702 ·Status: COMPLETED
-
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
NCT05616078 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts.
NCT06718192 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts.
NCT04654091 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma
NCT01808950 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial
NCT00254280 ·Status: UNKNOWN ·Phase: NA